Saved in:
| 主要作者: | |
|---|---|
| 格式: | Recurso digital |
| 語言: | |
| 出版: |
Zenodo
2025
|
| 主題: | |
| 在線閱讀: | https://doi.org/10.5281/zenodo.17841198 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
書本目錄:
- Patients taking dronedarone and rivaroxaban should have regular cardiac and liver function monitoring, with vigilance for bleeding risks, given the potential for increased bleeding when these drugs are combined.